24.85
24.85 (0%)
As of Feb 14, 2025
Schrodinger, Inc. [SDGR]
Source:
Company Overview
Schrodinger, Inc is transforming the way therapeutics and materials are discovered. Our differentiated, physics-based computational platform enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at a lower cost, compared to traditional methods.
| Country | United States |
| Headquarters | new york, new york |
| Phone Number | 503-299-1150 |
| Industry | manufacturing |
| CEO | Ramy Farid, Ph.D. |
| Website | www.schrodinger.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $207.5 |
| Operating Profit | $-209.3 |
| Net Income | $-187.1 |
| Net Cash | $1.6 |
Profit Ratios
| Gross Margin | $132.1 |
| Operating Margin | -100.9 |
| Profit as % of Revenues | -70.6% |
| Profit as % of Assets | -23% |
| Profit as % of Stockholder Equity | -44.4% |
Management Effectiveness
| Return on Equity | -44.4% |
| Return on Assets | -22.7% |
| Turnover Ratio | 25.5% |
| EBITA | $-209.3 |
Balance Sheet and Cash Flow Measures
| Total Assets | $823.2 |
| Total Liabilities | $401.8 |
| Operating Cash Flow | $-157.4 |
| Investing Cash Flow | $148.8 |
| Financing Cash Flow | $10.1 |
